Trial intelligence / Profile preview

Epsilon-aminocaproic acid during orthotopic liver transplantation

ChiCTR-TRC-11001662Phase 4Completed

Sponsor
First Affiliated Hospital, Zhejiang University School of Medicine
Start
Nov 2009
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of aminocaproic acid in coagulation defects (2 arms), sponsored by First Affiliated Hospital, Zhejiang University School of Medicine. Primary endpoint: Activated protein C concentration. Started Nov 2009; status: completed.

02

Drugs

aminocaproic acid
03

Conditions

coagulation defects

Beyond the preview

Go deeper on ChiCTR-TRC-11001662.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-TRC-11001662.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call